| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.042 | 0.3 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |